Latest Contraceptive patch Stories
DALLAS, January 20, 2015 /PRNewswire/ -- MarketReportsOnline.com adds Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19) industry
Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System PRINCETON, N.J., July 17, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a
Expands Patent Portfolio for its Contraceptive Patch, Twirla(TM) PRINCETON, N.J., June 20, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's health specialty
PRINCETON, N.J., June 18, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of
PITTSBURGH, April 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc.
Former FDA Director of the Division of Reproductive and Urologic Products/CDER, Dr. Daniel A. Shames Joins Agile Therapeutics Scientific Advisory Board PRINCETON, N.J., Feb.
PRINCETON, N.J., Feb.
DUBLIN, January 13, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/j3nzxd/contraceptives) has announced the addition of
PRINCETON, N.J., Jan.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.